FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064752893> ?p ?o ?g. }

• W2064752893 endingPage "2413" @default.
• W2064752893 startingPage "2401" @default.
• W2064752893 abstract "Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects. The present study evaluated the effect of atorvastatin added to interferon beta-1b in multiple sclerosis (MS) in a multicenter, randomized, parallel-group, rater-blinded study performed in eight Swiss hospitals. Seventy-seven patients with relapsing-remitting MS started interferon beta-1b every other day. After 3 months, they were randomized 1:1 to receive atorvastatin 40 mg/day or not in addition to interferon beta-1b until month 15. The primary endpoint was the proportion of patients with new lesions on T2-weighted images at month 15 compared to baseline at month three. At study end, the proportion of patients with new lesions on T2-weighted images was equal in both groups (odds ratio 1.14; 95 % CI 0.36–3.56; p = 0.81). All predefined secondary endpoints including number of new lesions and total lesion volume on T2-weighted images, total number of new Gd-enhancing lesions on T1-weighted images, total brain volume, volume of grey matter, volume of white matter, EDSS, MSFC, relapse rate, time to first relapse, number of relapse-free patients and neutralizing antibodies did not show any significant differences (all p values >0.1). Transient elevations of liver enzymes were more frequent with atorvastatin (p = 0.02). In conclusion, atorvastatin 40 mg/day in addition to interferon beta-1b did not have a beneficial effect on relapsing-remitting MS compared to interferon beta-1b monotherapy over a 12-month period." @default.
• W2064752893 created "2016-06-24" @default.
• W2064752893 creator A5009322556 @default.
• W2064752893 creator A5013666606 @default.
• W2064752893 creator A5020018472 @default.
• W2064752893 creator A5023557998 @default.
• W2064752893 creator A5026073467 @default.
• W2064752893 creator A5028035051 @default.
• W2064752893 creator A5031132136 @default.
• W2064752893 creator A5044484128 @default.
• W2064752893 creator A5044640285 @default.
• W2064752893 creator A5045991995 @default.
• W2064752893 creator A5054874316 @default.
• W2064752893 creator A5057570221 @default.
• W2064752893 creator A5065433523 @default.
• W2064752893 creator A5072898802 @default.
• W2064752893 creator A5073979365 @default.
• W2064752893 creator A5078853423 @default.
• W2064752893 creator A5082167581 @default.
• W2064752893 date "2012-05-09" @default.
• W2064752893 modified "2023-10-16" @default.
• W2064752893 title "Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial" @default.
• W2064752893 cites W1525331105 @default.
• W2064752893 cites W1575729838 @default.
• W2064752893 cites W1965452646 @default.
• W2064752893 cites W1967957947 @default.
• W2064752893 cites W1980857453 @default.
• W2064752893 cites W1999895981 @default.
• W2064752893 cites W2011751201 @default.
• W2064752893 cites W2012636039 @default.
• W2064752893 cites W2016293389 @default.
• W2064752893 cites W2028313592 @default.
• W2064752893 cites W2031329453 @default.
• W2064752893 cites W2045680585 @default.
• W2064752893 cites W2053714231 @default.
• W2064752893 cites W2061238254 @default.
• W2064752893 cites W2072718666 @default.
• W2064752893 cites W2074996264 @default.
• W2064752893 cites W2091532059 @default.
• W2064752893 cites W2093744749 @default.
• W2064752893 cites W2096569053 @default.
• W2064752893 cites W2098613224 @default.
• W2064752893 cites W2112165124 @default.
• W2064752893 cites W2116887543 @default.
• W2064752893 cites W2139168645 @default.
• W2064752893 cites W2150378783 @default.
• W2064752893 cites W2154915423 @default.
• W2064752893 cites W2163182789 @default.
• W2064752893 cites W2165547142 @default.
• W2064752893 cites W2338977280 @default.
• W2064752893 cites W4210548604 @default.
• W2064752893 cites W4230920194 @default.
• W2064752893 cites W4243660532 @default.
• W2064752893 cites W68382272 @default.
• W2064752893 doi "https://doi.org/10.1007/s00415-012-6513-7" @default.
• W2064752893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3484273" @default.
• W2064752893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22569835" @default.
• W2064752893 hasPublicationYear "2012" @default.
• W2064752893 type Work @default.
• W2064752893 sameAs 2064752893 @default.
• W2064752893 citedByCount "31" @default.
• W2064752893 countsByYear W20647528932012 @default.
• W2064752893 countsByYear W20647528932013 @default.
• W2064752893 countsByYear W20647528932014 @default.
• W2064752893 countsByYear W20647528932015 @default.
• W2064752893 countsByYear W20647528932016 @default.
• W2064752893 countsByYear W20647528932017 @default.
• W2064752893 countsByYear W20647528932018 @default.
• W2064752893 countsByYear W20647528932019 @default.
• W2064752893 countsByYear W20647528932020 @default.
• W2064752893 countsByYear W20647528932021 @default.
• W2064752893 countsByYear W20647528932022 @default.
• W2064752893 crossrefType "journal-article" @default.
• W2064752893 hasAuthorship W2064752893A5009322556 @default.
• W2064752893 hasAuthorship W2064752893A5013666606 @default.
• W2064752893 hasAuthorship W2064752893A5020018472 @default.
• W2064752893 hasAuthorship W2064752893A5023557998 @default.
• W2064752893 hasAuthorship W2064752893A5026073467 @default.
• W2064752893 hasAuthorship W2064752893A5028035051 @default.
• W2064752893 hasAuthorship W2064752893A5031132136 @default.
• W2064752893 hasAuthorship W2064752893A5044484128 @default.
• W2064752893 hasAuthorship W2064752893A5044640285 @default.
• W2064752893 hasAuthorship W2064752893A5045991995 @default.
• W2064752893 hasAuthorship W2064752893A5054874316 @default.
• W2064752893 hasAuthorship W2064752893A5057570221 @default.
• W2064752893 hasAuthorship W2064752893A5065433523 @default.
• W2064752893 hasAuthorship W2064752893A5072898802 @default.
• W2064752893 hasAuthorship W2064752893A5073979365 @default.
• W2064752893 hasAuthorship W2064752893A5078853423 @default.
• W2064752893 hasAuthorship W2064752893A5082167581 @default.
• W2064752893 hasBestOaLocation W20647528931 @default.
• W2064752893 hasConcept C118552586 @default.
• W2064752893 hasConcept C126322002 @default.
• W2064752893 hasConcept C16568411 @default.
• W2064752893 hasConcept C168563851 @default.
• W2064752893 hasConcept C203014093 @default.
• W2064752893 hasConcept C203092338 @default.
• W2064752893 hasConcept C2777482532 @default.

• next